Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Patterson fiscal 1Q profit rises 20 percent

August 26, 2010 4:45 am | by The Associated Press | News | Comments

Dental and veterinary products supplier Patterson Cos. Inc. said Thursday its fiscal first quarter profit climbed 20 percent, as sales for its two largest businesses rose and the company had an extra week in the quarter.The St. Paul, Minn., company said its net income rose to $53.9 million, or...

Artificial Cornea Offers Long-Term Vision

August 25, 2010 8:33 pm | by Massachusetts Institute of Technology | News | Comments

The results of a two-year study are as good as those achieved with donor corneas.

Medicare Approves New Technology Add-On Payments of up to $53,000 for SynCardia's Total Artificial Heart Through FY 2011

August 25, 2010 6:34 pm | by SynCardia | News | Comments

On Aug. 16, the Centers for Medicare and Medicaid Services (CMS) published its FY 2011 Hospital Inpatient Prospective Payment System (PPS) final rule, approving new technology add-on payments of up to $53,000 for the SynCardia temporary Total Artificial Heart (TAH-t) through FY 2011. The...

TOPICS:
Advertisement

Medical company MAKO names new director

August 25, 2010 2:45 pm | by The Associated Press | News | Comments

Medical device company MAKO Surgical Corp. said Wednesday that Richard Pettingill has joined the company's board of directors.Pettingill was president and chief executive officer of Allina Hospitals and Clinics, Minnesota's largest health care organization, from 2002 until his retirement in...

JCI table of contents: Aug. 25, 2010

August 25, 2010 2:32 pm | by EurekAlert | News | Comments

(Journal of Clinical Investigation) This release contains summaries, links to PDFs, and contact information for papers to be published Aug. 25, 2010, in the JCI: Applying stem cell technology to liver diseases; Antifreeze molecule enhances survival of bacteria-carrying ticks; Immune...

TOPICS:

Use the common cold virus to target and disrupt cancer cells?

August 25, 2010 2:31 pm | by EurekAlert | News | Comments

(Salk Institute) A novel mechanism used by adenovirus to sidestep the cell's suicide program, could go a long way to explain how tumor suppressor genes are silenced in tumor cells and pave the way for a new type of targeted cancer therapy, report researchers at the Salk Institute for...

TOPICS:

Hansen Medical, St. Jude become partners

August 25, 2010 1:45 pm | by The Associated Press | News | Comments

Hansen Medical Inc. said Wednesday it signed a deal with St. Jude Medical to sell new products based on their technologies for treating heart rhythm disorders.Terms of the deal were not disclosed.Hansen said the deal will integrate St. Jude's EnSite Velocity Cardiac Mapping System with Hansen's...

University of Pennsylvania-led study identifies new genetic risk factor for Lou Gehrig's disease

August 25, 2010 1:39 pm | by EurekAlert | News | Comments

(University of Pennsylvania) An international study led by biologists and neuroscientists from the University of Pennsylvania has identified a new genetic risk factor for amyotrophic lateral sclerosis, commonly known as ALS or Lou Gehrig's disease.

TOPICS:
Advertisement

MEMSIC introduces industry's first low-drift Mems vertical Gyro

August 25, 2010 1:39 pm | by I-Micronews | News | Comments

VG800 - precision IMU + attitude Angles for navigation and stabilization

Bestech Australia offers low noise MEMS gyroscopes from Gladiator technologies

August 25, 2010 1:39 pm | by I-Micronews | News | Comments

Bestech Australia presents the all new G100Z range of gyroscopes from Gladiator Technologies.

Qualcomm to spend $2 billion on e-ink-busting mirasol display plant

August 25, 2010 1:39 pm | by I-Micronews | News | Comments

According to an article from Journalist Kit Eaton, Qualcomm is about to invest some $2 billion in small change in a new plant for Mirasol displays--the half-LCD/half-e-ink screen tech that can play video in sunlight. It's all thanks to a "major client." Are we talking Amazon here?

New Cancer Drug Gets Dramatic Results

August 25, 2010 1:39 pm | by Massachusetts Institute of Technology | News | Comments

Researchers call the experimental drug a major success for targeted cancer therapies.

Pancreatic cancer research moving forward

August 25, 2010 1:37 pm | by Baylor College of Medicine | News | Comments

The Elkins Pancreas Center at Baylor College of Medicine , in partnership with the NCI-designated Dan L. Duncan Cancer Center at BCM, works to find new, more effective therapies for pancreatic cancer through clinical and basic science research. "When people talk about pancreatic cancer it...

TOPICS:

ViewRay Secures Series C Financing

August 25, 2010 1:37 pm | by Bio-Medicine.Org | News | Comments

CLEVELAND, Aug. 25 /- ViewRay™, Inc., a privately held medical device company, has secured $20 million in Series C financing led by new investor Siemens Venture Capital (SVC) GmbH and joined by existing investors Aisling Capital, Fidelity Biosciences, Kearny Venture Partners and...

TOPICS:

Ambry Genetics Announces the Addition of Illumina HiSeq 2000 and First 510(K) Approved BeadXpress® to Its Sequencing and Genotyping Capabilities

August 25, 2010 1:37 pm | by Bio-Medicine.Org | News | Comments

ALISO VIEJO, Calif., Aug. 25 /- Ambry Genetics, a global leader in genomic services, announced today that it has acquired the Illumina HiSeq 2000 Next Generation Sequencing System as well as received the first 510(K) approved Illumina BeadXpress Genotyping System. Ambry Genetics has been...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading